Erectile Dysfunction

MUSE Reported Highly Effective in Radical Prostatectomy Patients

Published in Sex Weekly Plus, November 2nd, 1998

In a clinical setting, MUSE (alprostadil) allowed 70 percent of men with severe impotence to achieve an erection sufficient for intercourse.

The data were published in the October 1998 issue of The Journal of Urology by Vivus, Inc., Mountain View, California, researchers.

Of these men, 57 percent reported successful sexual intercourse during home treatment. All 384 patients studied had undergone radical prostatectomy at least three months before study entry and had identified the surgery as the cause of their erectile dysfunction.

"I believe that MUSE is an excellent treatment alternative for men after radical prostatectomy,"...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Sex Weekly Plus

Source: Sex Weekly Plus (1998-11-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry